N

Neumora Therapeutics Inc
NASDAQ:NMRA

Watchlist Manager
Neumora Therapeutics Inc
NASDAQ:NMRA
Watchlist
Price: 1.78 USD
Market Cap: 293.3m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of NMRA.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NMRA Intrinsic Value
Not Available
Base Case Scenario
Compare NMRA to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about NMRA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Neumora Therapeutics Inc

Current Assets 177.1m
Cash & Short-Term Investments 171.5m
Other Current Assets 5.6m
Non-Current Assets 751k
PP&E 554k
Other Non-Current Assets 197k
Current Liabilities 25.8m
Accounts Payable 549k
Accrued Liabilities 25.2m
Other Current Liabilities 55k
Non-Current Liabilities 19.8m
Long-Term Debt 19.6m
Other Non-Current Liabilities 267k
Efficiency

Free Cash Flow Analysis
Neumora Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Neumora Therapeutics Inc

Revenue
0 USD
Operating Expenses
-240.6m USD
Operating Income
-240.6m USD
Other Expenses
4.3m USD
Net Income
-236.3m USD
Fundamental Scores

NMRA Profitability Score
Profitability Due Diligence

Neumora Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Declining ROE
hidden
Profitability
Score

Neumora Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

NMRA Solvency Score
Solvency Due Diligence

Neumora Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Neumora Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NMRA Price Targets Summary
Neumora Therapeutics Inc

Wall Street analysts forecast NMRA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NMRA is 9.35 USD with a low forecast of 3.03 USD and a high forecast of 18.9 USD.

Lowest
Price Target
3.03 USD
70% Upside
Average
Price Target
9.35 USD
425% Upside
Highest
Price Target
18.9 USD
962% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Neumora Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for NMRA is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

NMRA Insider Trading
Buy and sell transactions by insiders

NMRA News

Other Videos